Skip to main content
WAT
NYSE Industrial Applications And Services

Waters Beats Q3, Raises 2026 Guidance by $43M and Discloses MOBILion Acquisition

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$456
Mkt Cap
$44.165B
52W Low
$282.77
52W High
$482.28
52W Position info
61% above low
Off High info
5.4% below high
Rel. Volume info
2.4× avg
Market data snapshot near publication time

WAT sits 61% above its 52-week low of $282.77 on elevated volume (2.4× avg).

Summary

Waters beat Q3 estimates with $1.767 billion of revenue and $4.10 adjusted EPS, raised full-year 2026 guidance by $43 million at the midpoint, and disclosed the acquisition of MOBILion Systems.


Key Events · Earnings and Guidance · WAT

  • Q3 Beat on Both Lines

    Revenue of $1.767 billion exceeded the guidance midpoint by $14 million, with organic constant-currency growth of 10%; adjusted EPS of $4.10 grew 21% and beat guidance.

  • Full-Year Guidance Raised $43M

    2026 total revenue guidance lifted to $6.479-$6.497 billion and adjusted EPS to $14.60-$14.70, representing 11%-12% year-over-year growth.

  • Q4 Outlook Calls for Double-Digit Growth

    Fourth quarter revenue guided to $1.801-$1.819 billion with organic constant-currency growth of 7.0%-9.0% and adjusted EPS of $4.58-$4.68.

  • MOBILion Acquisition Disclosed

    Waters announced it acquired MOBILion Systems, adding SLIM high-resolution ion mobility separation technology and broadening its entry into the proteomics market; terms were not stated in this release.


Analysis · WAT · Industrial Applications And Services

The headline beat is only part of the story: Waters raised every component of its 2026 outlook, lifting revenue at the midpoint by $43 million and setting adjusted EPS of $14.60-$14.70, which implies 11%-12% growth. Organic constant-currency growth of 10% in the quarter shows the core franchise is accelerating, not just the acquired BD businesses. The filing also discloses the MOBILion Systems acquisition, adding ion mobility technology to the mass spectrometry portfolio and an entry into proteomics. GAAP optics are the offset: purchase accounting and restructuring drove a $0.82 GAAP EPS against $4.10 adjusted, and the balance sheet now carries $5.1 billion of debt from the BDS deal.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, WAT was trading at $456.00 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $44.2B. The 52-week trading range was $282.77 to $482.28. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

WAT - Latest Insights

WAT
Nov 10, 2026, 4:31 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $475.52
Real-time Price: $465.87 info
Change: -$9.65 (-2%) info
Market Cap: $45.811B info
WAT
Nov 03, 2026, 6:12 AM EST
Source: Reuters
Importance Score:
8
Price at Filing: $457.00
Real-time Price: $465.87 info
Change: +$8.87 (+2%) info
Market Cap: $45.811B info
WAT
Aug 11, 2026, 4:16 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $414.59
Real-time Price: $465.87 info
Change: +$51.28 (+12%) info
Market Cap: $45.811B info
WAT
Aug 04, 2026, 7:04 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $373.00
Real-time Price: $465.87 info
Change: +$92.87 (+25%) info
Market Cap: $45.811B info
WAT
Aug 04, 2026, 6:10 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $364.69
Real-time Price: $465.87 info
Change: +$101.18 (+28%) info
Market Cap: $45.811B info